You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy

Article info

Article menu
XML
Immunotherapy biomarkers
Original research
Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy

Authors

  • Afaf Abed School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia Linear Clinical Research, Nedlands, Western Australia, Australia Department of Medical Oncology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Leslie Calapre School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Johnny Lo School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Suzana Correia Department of Medical Oncology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Samantha Bowyer Linear Clinical Research, Nedlands, Western Australia, Australia Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Abha Chopra Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Mark Watson Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Muhammad Adnan Khattak School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia Department of Medical Oncology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Michael Millward Linear Clinical Research, Nedlands, Western Australia, Australia Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia School of Medicine, The University of Western Australia, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Elin Solomonovna Gray School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Afaf Abed; afaf.abed{at}health.wa.gov.au
View Full Text

Citation

Abed A, Calapre L, Lo J, et al
Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy
Journal for ImmunoTherapy of Cancer 2020;8:e001620. doi: 10.1136/jitc-2020-001620

Publication history

  • Accepted October 27, 2020
  • First published November 23, 2020.
Online issue publication 
November 23, 2020

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.